Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line

European Journal of Clinical Investigation

Volumn 29, Issue 8, 1999, Pages 717-722

  Benfield, T L ^a   Lundgren, B ^a   Shelhamer, J H ^b   Lundgren, J D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Alvedar epithelium; IL 8; MCP 1; Pneumocystis carinii

Indexed keywords

BETA GLUCAN; DEXAMETHASONE; GLYCOPROTEIN; INTERLEUKIN 8; MANNAN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; RIBONUCLEASE PROTECTION ASSAY;

EID: 0032802639     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00517.x     Document Type: Article

References (34)

1. 1 Benfield TL, Prentø P, Junge J, Vestbo J, Lundgren JD. Alveolar damage in AIDS-associated Pneumocystis carinii pneumonia. Chest 1997; 111: 1193-9.
2. 2 Lanken PN, Minda M, Pietra GG, Fishman AP. Alveolar response to experimental Pneumocystis carinii pneumonia in the rat. Am J Pathol 1980; 99: 561-88.
3. 3 Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestation of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Am J Surg Pathol 1990; 14: 615-26.
4. 4 Vestbo J, Nielsen TL, Junge J, Lundgren JD. Amount of Pneumocystis carinii and degree of acute lung inflammation in HIV-associated P. carinii pneumonia. Chest 1993; 104: 109-13.
5. 5 Smith RL, El-Sadr WM, Lewis ML. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 1988; 92: 60-4.
6. 6 Mason GR, Hashimoto CH, Dickman PS, Foutty LF, Cobb CJ. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 1989; 139: 1336-42.
7. 7 Sadaghdar H, Huang ZB, Eden E. Correlation of bronchoalveolar lavage findings to severity of Pneumocystis carinii pneumonia in AIDS. Chest 1992; 102: 63-9.
8. 8 Limper AH, Offord KP, Smith TF, Martin WJI. Pneumocystis carinii pneumonia: Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140: 1204-9.
9. 9 Kunkel SL, Standiford TJ, Kasahara K, Strieter RM. Interleukin-8: the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17: 17-23.
10. 10 Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1991; 169: 1485-94.
11. 11 Taub DD, Proost P, Murphy WJ, et al. Monocytic chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995; 95: 1370-6.
12. 12 Beck JM, Preston AM, Wagner JG, et al. Interaction of rat Pneumocystis carinii and rat alveolar cells in vitro. Am J Physiol 1998; 275: L118-25.
13. 13 Lundgren B, Lipschik GY, Kovacs JA. Purification and characterization of a major human Pneumocystis carinii surface antigen. J Clin Invest 1991; 87: 163-70.
14. 15 Benfield TL, Lundgren B, Lundgren JD, Shelhamer JHMSG, of P. carinii induces gene expression and secretion of IL-6 and 8 in alveolar epithelium (Abstract). Am J Resp Crit Care Med 1996; 153: A695.
15. 16 Limper AH, Pottratz ST, Martin WJ II. Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. J Lab Clin Med 1991; 118: 492-9.
16. 17 Hoffman OA, Standing JE, Limper AH. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J Immunol 1993; 150: 3932-40.
17. 18 Ezekowitz RAB, Williams DJ, Koziel H, et al. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991; 351: 155-8.
18. 19 Theus SA, Linke MJ, Andrews RP, Walzer PD. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Infect Immun 1993; 61: 4703-9.
19. 20 Jung HC, Eckmann L, Yang S-K, Panja A, Fierer J, Morzycka-Wroblewska E. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55-65.
20. 21 DiMango E, Zar HJ, Bryan R, Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995; 96: 2204-10.
21. 22 Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. J Clin Invest 1998; 66: 1121-6.
22. 23 Pottratz ST, Reese S, Sheldon JL. Pneumocystis carinii induces interleukin 6 production by an alveolar epithelial cell line. Eur J Clin Invest 1998; 28: 424-9.
23. 24 Yu ML, Limper AH. Pneumocystis carinii induces ICAM-1 expression in lung epithelial cells through a TNF-alpha-mediated mechanism. Am J Physiol 1997; 272: L1103-L1111.
24. 25 Lipschik GY, Treml JF, Moore SD. Pneumocystis carinii glycoprotein A stimulates interleukin-8 production and inflammatory cell activation in alveolar macrophages and cultured monocytes. J Eukaryot Microbiol 1996; 43: 16S-17S.
25. 26 Benfield TL, van Steenwijk R, Nielsen TL, et al. Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS, a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. Respir Med 1995; 89: 285-90.
26. 27 Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen AB, Lundgren JD. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995; 151: 1058-62.
27. 28 Benfield TL, Lundgren JD. TNF-alpha and MCP-1 during HIV-related Pneumocystis carinii pneumonia: relation to prognosis. Am J Respir Crit Care Med 1998; 157: A235.
28. 29 Erik Hack C, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997; 66: 101-95.
29. 30 Benfield TL, Lundgren JD. The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis. FEMS Immunol Med Microbiol 1998; 22: 129-34.
30. 31 Bozzette SA, Morton SC. Reconsidering the use of adjunctive corticosteroids in Pneumocystis pneumonia? J AIDS 1995; 8: 345-7.
31. 32 Huang ZB, Eden E. Effect of corticosteroids on IL1 b and TNFa release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 1993; 104: 751-5.
32. 33 Limper AH, Martin WJ II. Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J Clin Invest 1990; 85: 391-6.
33. 34 Pottratz ST, Martin WJ II. Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest 1990; 85: 351-6.
34. 35 Lipschik GY, Treml JF, Moore SD, Beers MF. Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by rat alveolar type II cells. J Infect Dis 1998; 177: 182-7.